Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumar, Anil-
dc.contributor.authorKulkarni, S K-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.description.abstractParkinson’s disease (PD) is a neurodegenerative disease characterized by the selective loss of dopamine (DA) neurons of the substantia nigra pars compacta (SNc). The events, which trigger and/or mediate the loss of nigral DA neurons, however, remain unclear. Neuroleptic-induced catalepsy has long been used as an animal model for screening drugs for Parkinsonism. Administration of haloperidol (1 mg/kg, ip) or reserpine (2 mg/kg, ip) significantly induced catalepsy in mice. BR-16A (50 and 100 mg/kg, po), a polyherbal formulation or ashwagandha (50 and 100 mg/kg, po), significantly reversed the haloperidol or reserpine-induced catalepsy. The results indicate that BR-16A or ashwagandha has protective effect against haloperidol or reserpine-induced catalepsy and provide hope that BR-16A could be used in preventing the drug-induced extrapyramidal side effects and may offer a new therapeutic approach to the treatment of Parkinson's disease. en_US
dc.relation.ispartofseriesInt Cl7 A61 Pen_US
dc.sourceIJEB Vol.44(01) [January 2006]en_US
dc.titleEffect of BR-16A (Mentat®), a polyherbal formulation on drug-induced catalepsy in miceen_US
Appears in Collections:IJEB Vol.44(01) [January 2006]

Files in This Item:
File Description SizeFormat 
IJEB 44(1) 45-48.pdf70.9 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.